| REVIEW ARTICLE |
|
| Year : 2013 | Volume
: 7
| Issue : 3 | Page : 322-326 |
|
|
Tapentadol hydrochloride: A novel analgesic
Dewan Roshan Singh, Kusha Nag, Akshaya N Shetti, N Krishnaveni
Department of Anaesthesiology and Critical Care, Mahatma Gandhi Medical College, Pillaiyarkuppam, Pondicherry, India
Correspondence Address:
Dewan Roshan Singh
Department of Anaesthesiology and Critical Care, Mahatma Gandhi Medical College, Pillaiyarkuppam, Pondicherry 607 402
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1658-354X.115319
|
|
|
Tapentadol is a novel, centrally acting analgesic with dual mechanism of action, combining mu-opioid receptor agonism with noradrenaline reuptake inhibition in the same molecule. It has an improved side effect profile when compared to opioids and nonsteroidal anti-inflammatory drugs. The dual mechanism of action makes Tapentadol a useful analgesic to treat acute, chronic, and neuropathic pain. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
